Financhill
Sell
43

GCO Quote, Financials, Valuation and Earnings

Last price:
$24.38
Seasonality move :
8.85%
Day range:
$22.05 - $26.50
52-week range:
$16.19 - $44.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.11x
P/B ratio:
0.52x
Volume:
751.8K
Avg. volume:
130.7K
1-year change:
-36.16%
Market cap:
$263.2M
Revenue:
$2.3B
EPS (TTM):
-$0.18

Analysts' Opinion

  • Consensus Rating
    Genesco, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $30.33, Genesco, Inc. has an estimated upside of 39.46% from its current price of $24.38.
  • Price Target Downside
    According to analysts, the lowest downside price target is $26.00 representing -6.65% downside risk from its current price of $24.38.

Fair Value

  • According to the consensus of 3 analysts, Genesco, Inc. has 39.46% upside to fair value with a price target of $30.33 per share.

GCO vs. S&P 500

  • Over the past 5 trading days, Genesco, Inc. has underperformed the S&P 500 by -30.96% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Genesco, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Genesco, Inc. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Genesco, Inc. reported revenues of $616.2M.

Earnings Growth

  • Genesco, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Genesco, Inc. reported earnings per share of $0.50.
Enterprise value:
812.3M
EV / Invested capital:
--
Price / LTM sales:
0.11x
EV / EBIT:
50.65x
EV / Revenue:
0.34x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
43.24x
Price / Operating cash flow:
13.79x
Enterprise value / EBITDA:
11.78x
Gross Profit (TTM):
$1.1B
Return On Assets:
-1.79%
Net Income Margin (TTM):
-1.06%
Return On Equity:
-4.76%
Return On Invested Capital:
-2.29%
Operating Margin:
-2.62%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-10-31 2024-10-31 2025-10-31 2024-10-31 2025-10-31
Income Statement
Revenue $2.3B $2.3B $2.4B $596.3M $616.2M
Gross Profit $1.1B $1.1B $1.1B $285.3M $288.6M
Operating Income $29.1M $7.8M $18.6M $10.3M $12.9M
EBITDA $75.5M $61.3M -- $23.4M --
Diluted EPS -$0.58 -$2.44 -$0.18 -$1.76 $0.50
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Balance Sheet
Current Assets $744.4M $681.8M $638.7M $659.7M $689.1M
Total Assets $1.6B $1.5B $1.5B $1.4B $1.5B
Current Liabilities $474M $445.4M $397.2M $422.1M $436M
Total Liabilities $1B $977.7M $956M $918.6M $958.3M
Total Equity $592.4M $559.3M $537M $516.9M $513.8M
Total Debt $650.4M $502.5M $515.5M $448.8M --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-07-31 2024-07-31 2025-07-31 2024-07-31 2025-07-31
Cash Flow Statement
Cash Flow Operations $34.2M $113.9M $79.2M $27.7M $86.3M
Cash From Investing -$66.1M -$39.1M -$60.4M -$7.9M -$14.7M
Cash From Financing $24.3M -$65.8M -$23M $6.7M -$52.4M
Free Cash Flow -$32M $74.6M $18.8M $19.8M $71.7M
GCO
Sector
Market Cap
$263.2M
$324.5M
Price % of 52-Week High
54.42%
73.51%
Dividend Yield
0%
0%
Shareholder Yield
0.14%
2.01%
1-Year Price Total Return
-36.16%
-6.69%
Beta (5-Year)
1.751
0.547
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $33.67
200-day SMA
Sell
Level $26.16
Bollinger Bands (100)
Sell
Level 25.92 - 32.92
Chaikin Money Flow
Buy
Level 37.6M
20-day SMA
Sell
Level $32.27
Relative Strength Index (RSI14)
Sell
Level 28.92
ADX Line
Sell
Level 24.51
Williams %R
Buy
Level -83.9261
50-day SMA
Sell
Level $30.51
MACD (12, 26)
Buy
Level 0.54
25-day Aroon Oscillator
Sell
Level -12
On Balance Volume
Neutral
Level 43.2M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.6237)
Buy
CA Score (Annual)
Level (-0.0908)
Buy
Beneish M-Score (Annual)
Level (-3.192)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.8936)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Genesco, Inc. engages in sourcing and design, marketing, and distribution of footwear, apparel, and accessories. It operates through the following business segments: Journeys Group, Schuh Group, Johnston and Murphy Group, and Genesco Brands Group. The Journeys Group segment operates the Journeys, Journeys Kidz, and Little Burgundy retail stores retail footwear chain. The Schuh Group segment includes the Schuh retail footwear chain and e-commerce operations. The Johnston and Murphy Group segment operates the wholesale distribution of products under the Johnston and Murphy brand. The Genesco Brands Group segment is involved in licensed Dockers, Levi's, and G.H. Bass brands. The company was founded in 1924 and is headquartered in Nashville, TN.

Stock Forecast FAQ

In the current month, GCO has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The GCO average analyst price target in the past 3 months is $30.33.

  • Where Will Genesco, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Genesco, Inc. share price will rise to $30.33 per share over the next 12 months.

  • What Do Analysts Say About Genesco, Inc.?

    Analysts are divided on their view about Genesco, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Genesco, Inc. is a Sell and believe this share price will drop from its current level to $26.00.

  • What Is Genesco, Inc.'s Price Target?

    The price target for Genesco, Inc. over the next 1-year time period is forecast to be $30.33 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is GCO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Genesco, Inc. is a Hold. 2 of 3 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of GCO?

    You can purchase shares of Genesco, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Genesco, Inc. shares.

  • What Is The Genesco, Inc. Share Price Today?

    Genesco, Inc. was last trading at $24.38 per share. This represents the most recent stock quote for Genesco, Inc.. Yesterday, Genesco, Inc. closed at $24.38 per share.

  • How To Buy Genesco, Inc. Stock Online?

    In order to purchase Genesco, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 18.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock